Found: 9
Select item for more details and to access through your institution.
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 7, p. 4077, doi. 10.1007/s00432-022-04294-6
- By:
- Publication type:
- Article
Oral drugs in the treatment of metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211009001
- By:
- Publication type:
- Article
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.6776
- By:
- Publication type:
- Article
Regorafenib in Advanced Colorectal Cancer.
- Published in:
- Cancer & Chemotherapy Reviews, 2017, v. 12, n. 1, p. 3
- By:
- Publication type:
- Article
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Carisoprodol Single and Multiple Dose PK-PD. Part II: Pharmacodynamics Evaluation Method for Central Muscle Relaxants. Double-Blind Placebo-Controlled Clinical Trial in Healthy Volunteers.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 4, p. N.PAG, doi. 10.3390/jcm11041141
- By:
- Publication type:
- Article
Single and Multiple Dose PK–PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 3, p. 858, doi. 10.3390/jcm11030858
- By:
- Publication type:
- Article
DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 8, p. 792, doi. 10.3390/jpm11080792
- By:
- Publication type:
- Article
Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 6, p. 413, doi. 10.1007/s12094-012-0818-y
- By:
- Publication type:
- Article